Income Statement
ARCADIA BIOSCIENCES, INC.
RKDA
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
4.86 | 5.05 | 5.33 | 9.96 | 6.78 | 8.03 | 1.17 | 1.46 | 4.03 | 3.19 | 5.41 |
|
Cost of Revenue
|
3.10 | 2.96 | 3.30 | 9.80 | 8.71 | 5.20 | 0.89 | 0.66 | - | - | - |
|
Gross Profit
|
1.76 | 2.08 | 2.03 | 0.15 | -1.93 | 2.84 | 0.28 | 0.80 | 4.03 | 3.19 | 5.41 |
|
Operating Expenses
|
7.01 | 9.69 | 15.90 | 19.56 | 26.83 | 20.81 | 20.55 | 18.33 | 18.34 | 21.81 | 20.98 |
|
Research & Development
|
0.01 | 0.05 | 1.39 | 1.51 | 3.89 | 7.96 | 7.10 | 6.07 | 7.41 | 8.66 | 8.97 |
|
Selling, General & Administrative
|
7.00 | 9.64 | 14.51 | 18.05 | 22.94 | 16.47 | 13.57 | 11.60 | 10.65 | 12.25 | 11.12 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-5.25 | -7.61 | -13.87 | -19.40 | -28.76 | -17.98 | -20.27 | -17.53 | -14.32 | -18.62 | -15.56 |
|
Non-Operating Income
|
-2.92 | -3.30 | -0.71 | - | - | - | - | - | 1.37 | 0.98 | 2.37 |
|
Interest Income
|
- | - | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
- | - | - | - | 0.02 | 0.05 | 0.01 | - | 0.75 | 1.32 | 2.66 |
|
Other Non-Op Income / Expense
|
2.31 | 0.03 | 0.05 | 0.03 | 10.11 | 0.74 | 0.47 | 0.39 | 0.00 | 0.00 | 0.52 |
|
Income Before Tax
|
-2.33 | -4.31 | -13.16 | -15.60 | -16.13 | -6.15 | -28.87 | -13.47 | -15.68 | -19.60 | -17.93 |
|
Income Tax Expense
|
0.01 | 2.73 | 0.82 | 0.01 | 0.00 | -0.12 | 0.00 | 0.01 | 0.03 | 0.03 | 0.03 |
|
Non-Controlling Interest
|
- | 0.00 | -0.01 | -0.24 | -1.47 | -1.37 | -0.07 | - | - | - | - |
|
Net Income
|
-2.34 | -7.04 | -13.98 | -15.38 | -14.66 | -4.66 | -28.81 | -13.48 | -15.71 | -19.62 | -17.96 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-5.25 | -7.61 | -13.87 | -19.40 | -28.76 | -17.98 | -20.27 | -17.53 | -14.04 | -18.32 | -15.27 |
|
Earnings Per Share (Basic)
|
-1.71 | -5.17 | - | -25.65 | - | - | - | - | - | - | - |
|
Diluted EPS
|
-1.71 | -5.17 | - | -25.65 | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
1.37 | 1.36 | 1.24 | 0.60 | - | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
1.37 | 1.36 | 1.24 | 0.60 | - | - | - | - | - | - | - |
|
Comprehensive Income
|
-2.34 | -7.14 | -13.88 | -15.38 | -14.66 | -4.66 | -28.80 | -13.48 | -15.69 | -19.53 | -20.84 |